Abstract
The government of India has heavily promoted research and development in regenerative medicine together with domestic innovation and business development initiatives. Together, these promise a revolution in healthcare and public empowerment in India. Several national and transnational linkages have emerged to develop innovative capacity, most prominently in stem cell and cord blood banking, as well as in gene therapy, tissue engineering, biomaterials and 3D printing. However, challenges remain of achieving regulatory oversight, viable outputs and equitable impacts. Governance of private cord blood banking, nanomaterials and 3D bioprinting requires more attention. A robust social contract is also needed in healthcare more generally, so that participation in research and innovation in regenerative medicine is backed up by treatments widely accessible to all.
| Original language | English |
|---|---|
| Pages (from-to) | 875-885 |
| Number of pages | 11 |
| Journal | Regenerative Medicine |
| Volume | 12 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Oct 2017 |
| Externally published | Yes |